Agios Pharmaceuticals, Inc. (AGIO) Operating cash flow 2016–2025
Agios Pharmaceuticals, Inc. (AGIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$373.0MFY2025 · since FY2016: $38.6M → -$373.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$373.0M | +4.3% |
| FY2024 | -$389.8M | -31.7% |
| FY2023 | -$296.1M | +4.3% |
| FY2022 | -$309.5M | +24.0% |
| FY2021 | -$407.3M | -40.1% |
| FY2020 | -$290.8M | +21.5% |
| FY2019 | -$370.6M | -21.7% |
| FY2018 | -$304.4M | -6.7% |
| FY2017 | -$285.2M | -839.7% |
| FY2016 | $38.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice